Compare Novartis AG (NVS) vs Riot Platforms Inc (RIOT) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Novartis AG vs Riot Platforms Inc — how do they compare? Novartis AG trades at $153.88 (market cap $290.25B), while Riot Platforms Inc trades at $21.55 (market cap $7.53B). The key difference: Novartis AG is far larger — about 38.5× Riot Platforms Inc's market cap, and Novartis AG pays a 3.17% dividend while Riot Platforms Inc pays none. Which is the better fit depends on your goals.
| NVS | RIOT | |
|---|---|---|
Market Cap | $290.25B | $7.53B |
Sector | Health | Technology |
52-Week High | $168.62 | $28.67 |
52-Week Low | $113.50 | $11.03 |
Enterprise Value | $330.27B | $8.20B |
Dividend Yield | 3.17% | — |
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Novartis AG
Novartis develops and manufactures healthcare products through two segments: Innovative Medicines and Sandoz. It generates the vast majority of its revenue from Innovative Medicines segment consisting global business franchises in oncology, ophthalmology, neuroscience, immunology, respiratory, cardio-metabolic, and established medicines. The company sells its products globally, with the United States representing close to one third of total revenue.
Read more on NVS →About Riot Platforms Inc
Riot Platforms, Inc. is a Bitcoin mining company that focuses on building, operating, and expanding large-scale infrastructure for digital asset mining in North America. The company's operations include Bitcoin mining, data center hosting, and engineering solutions. Riot's strategy emphasizes vertical integration to maximize efficiency and scale its mining capacity, aiming to be a leader in the global Bitcoin and digital infrastructure industry.
Read more on RIOT →
